Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Michael Thomas Barrett | |||||||
GSE240339 |
Genomic Landscape of Diploid and Aneuploid Microsatellite Stable Early Onset Colorectal Cancer
|
7 | Michael Thomas Barrett | Feb 21, 2024 | ||||
GSE233746 |
Phase II Clinical Trial of Nab-Paclitaxel (NAB)Plus Cisplatin (PLA) Plus Gemcitabine (GEM) (NABPLAGEM) in Patients with Untreated Advanced Pancreatic Cancer.
|
2 | Michael Thomas Barrett | Jun 30, 2023 | ||||
GSE230411 |
Patient-derived tumor xenograft study with CDK4/6 inhibitor plus AKT inhibitor for management of metastatic castrate resistant prostate cancer
|
3 | Michael Thomas Barrett | May 31, 2023 | ||||
GSE146670 |
Unique genomic and neoepitope landscapes across tumors: a study across time, tissues, and space within a single Lynch Syndrome patient
|
5 | Michael Thomas Barrett | Apr 30, 2020 | ||||
GSE123464 |
Clonal Analyses of Refractory Testicular Germ Cell Tumors
|
11 | Michael Thomas Barrett | Feb 26, 2019 | ||||
GSE107764 |
The Association of Genomic Lesions and PD-1/PD-L1 Expression in Resected Triple Negative Breast Cancers
|
48 | Michael Thomas Barrett | Nov 15, 2018 | ||||
GSE70003 |
Disseminated medulloblastoma in a child with germline BRCA2 6174delT mutation and without Fanconi anemia
|
2 | Michael Thomas Barrett | Jul 06, 2015 | ||||
GSE64462 |
Phase II study of therapy selected by tumor molecular profiling in patients with previously treated metastatic pancreatic cancer. A study of the Stand Up to Cancer (SU2C) study consortium
|
31 | Michael Thomas Barrett | Dec 31, 2014 | ||||
GSE54328 |
STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinoma
|
4 | Michael Thomas Barrett | Jan 24, 2014 | ||||
GSE40299 |
Deep Clonal Profiling of Formalin-Fixed Paraffin-Embedded Clinical Samples
|
23 | Michael Thomas Barrett | Dec 31, 2012 | ||||
GSE34063 |
Clonal Analysis for Identification of Molecular Pathways with Potential Therapeutic Implications in of Rare Gastrointestinal and Endocrine Cancers
|
17 | Michael Thomas Barrett | Apr 01, 2012 | ||||
GSE21660 |
Advancing a Clinically Relevant Perspective of the Clonal Nature of Cancer
|
61 | Michael Thomas Barrett | Jul 04, 2011 |